Skip to content
PubMed This is a summary of 129 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 129 referenced papers

Top Authors

Ahmedin Jemal
American Cancer Society
Jaffer A. Ajani
The University of Texas MD Anderson Cancer Center
Freddie Bray
Centre international de recherche sur le cancer
Rebecca L. Siegel
American Cancer Society
Andreas D. Hartkopf
University of Tübingen
Sara Y. Brucker
University of Tübingen
Jesper Lagergren
Karolinska Institutet
Rimda Wanchoo
Hofstra University
Melina Arnold
Centre international de recherche sur le cancer
Lenora A. Pluchino
National Comprehensive Cancer Network

Top Institutions

Ranked by publications Top 10 institutions
01

London School of Hygiene & Tropical Medicine

London, United Kingdom

16 papers
04

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing, China

268 papers
05

Sun Yat-sen University

Guangzhou, China

317 papers

References

References (129)
  1. 1

    Esophageal and esophagogastric junction cancers, version 1.2015.

    Ajani JA, D'Amico TA, Almhanna K, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2015; (13(2)):194-227 doi:10.6004/jnccn.2015.0028.

    PMID: 25691612
  2. 2

    Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

    Shapiro J, van Lanschot JJB, Hulshof MCCM, et al.

    The Lancet. Oncology 2015; (16(9)):1090-1098 doi:10.1016/S1470-2045(15)00040-6.

    PMID: 26254683
  3. 3

    Examination of Surgical Specimens of the Esophagus.

    Bejarano PA, Berho M

    Archives of pathology & laboratory medicine 2015; (139(11)):1446-54 doi:10.5858/arpa.2014-0506-RA.

    PMID: 26516942
  4. 4

    CROSS and beyond: a clinical perspective on the results of the randomized ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study.

    van der Woude SO, Hulshof MC, van Laarhoven HW

    Chinese clinical oncology 2016; (5(1)):13 doi:10.3978/j.issn.2304-3865.2016.02.04.

    PMID: 26932437
  5. 5

    Surgical Proficiency Gain and Survival After Esophagectomy for Cancer.

    Markar SR, Mackenzie H, Lagergren P, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016; (34(13)):1528-36 doi:10.1200/JCO.2015.65.2875.

    PMID: 26951311
  6. 6

    Concurrent Therapy with a Low-carbohydrate Diet and Miglitol Remarkably Improved the Postprandial Blood Glucose and Insulin Levels in a Patient with Reactive Hypoglycemia due to Late Dumping Syndrome.

    Hirose S, Iwahashi Y, Seo A, et al.

    Internal medicine (Tokyo, Japan) 2016; (55(9)):1137-42 doi:10.2169/internalmedicine.55.5655.

    PMID: 27150868
  7. 7

    Stage-directed individualized therapy in esophageal cancer.

    Goense L, van Rossum PS, Kandioler D, et al.

    Annals of the New York Academy of Sciences 2016; (1381(1)):50-65 doi:10.1111/nyas.13113.

    PMID: 27384385
  8. 8

    What's the Best Way to Treat GE Junction Tumors? Approach Like Gastric Cancer.

    Mullen JT, Kwak EL, Hong TS

    Annals of surgical oncology 2016; (23(12)):3780-3785 doi:10.1245/s10434-016-5426-6.

    PMID: 27459983
  9. 9

    Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.

    Rice TW, Lerut TE, Orringer MB, et al.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 2016; (29(7)):715-723 doi:10.1111/dote.12513.

    PMID: 27731548
  10. 10

    Incidence of Esophageal Carcinomas After Surgery for Achalasia: Usefulness of Long-Term and Periodic Follow-up.

    Ota M, Narumiya K, Kudo K, et al.

    The American journal of case reports 2016; (17()):845-849 doi:10.12659/ajcr.899800.

    PMID: 27840406
  11. 11

    HER2 testing in gastric cancer: results of a German expert meeting.

    Lordick F, Al-Batran SE, Dietel M, et al.

    Journal of cancer research and clinical oncology 2017; (143(5)):835-841 doi:10.1007/s00432-017-2374-x.

    PMID: 28285403
  12. 12

    Multidisciplinary Approach to the Management of Esophageal Malignancies.

    Joseph R, Laks S, Meyers M, McRee AJ

    World journal of surgery 2017; (41(7)):1726-1733 doi:10.1007/s00268-017-4009-4.

    PMID: 28361298
  13. 13

    Salvage esophagectomy for persistent or recurrent disease after definitive chemoradiation.

    Swisher SG, Marks J, Rice D

    Annals of cardiothoracic surgery 2017; (6(2)):144-151 doi:10.21037/acs.2017.03.02.

    PMID: 28447003
  14. 14

    Nutrition in peri-operative esophageal cancer management.

    Steenhagen E, van Vulpen JK, van Hillegersberg R, et al.

    Expert review of gastroenterology & hepatology 2017; (11(7)):663-672 doi:10.1080/17474124.2017.1325320.

    PMID: 28454509
  15. 15

    Definitive chemoradiotherapy.

    Stahl M, Budach W

    Journal of thoracic disease 2017; (9(Suppl 8)):S792-S798 doi:10.21037/jtd.2017.05.05.

    PMID: 28815076
  16. 16

    Salvage esophagectomy: safe therapeutic strategy?

    Jamel S, Markar SR

    Journal of thoracic disease 2017; (9(Suppl 8)):S799-S808 doi:10.21037/jtd.2017.05.09.

    PMID: 28815077
  17. 17

    Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial.

    Noordman BJ, Verdam MGE, Lagarde SM, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018; (36(3)):268-275 doi:10.1200/JCO.2017.73.7718.

    PMID: 29161204
  18. 18

    Impact of Sarcopenia on Unplanned Readmission and Survival After Esophagectomy in Patients with Esophageal Cancer.

    Makiura D, Ono R, Inoue J, et al.

    Annals of surgical oncology 2018; (25(2)):456-464 doi:10.1245/s10434-017-6294-4.

    PMID: 29214454
  19. 19

    Long-Term Nutritional Outcome and Health Related Quality of Life of Patients Following Esophageal Cancer Surgery: A Meta-Analysis.

    Soriano TT, Eslick GD, Vanniasinkam T

    Nutrition and cancer 2018; (70(2)):192-203 doi:10.1080/01635581.2018.1412471.

    PMID: 29281327
  20. 20

    HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Committee.

    Wong NACS, Amary F, Butler R, et al.

    Journal of clinical pathology 2018; (71(5)):388-394 doi:10.1136/jclinpath-2017-204943.

    PMID: 29439009
  21. 21

    Risk of GERD-Related Disorders in Obese Patients on PPI Therapy: a Population Analysis.

    Erridge S, Moussa OM, Ziprin P, et al.

    Obesity surgery 2018; (28(9)):2796-2803 doi:10.1007/s11695-018-3246-4.

    PMID: 29717405
  22. 22

    Vitamin B12 deficiency after esophagectomy with gastric tube reconstruction for esophageal cancer.

    van Hagen P, de Jonge R, van Berge Henegouwen MI, et al.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 2017; (30(12)):1-8 doi:10.1093/dote/dox102.

    PMID: 29800266
  23. 23

    Endoscopic submucosal dissection for superficial esophageal cancer.

    Aadam AA, Abe S

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 2018; (31(7)) doi:10.1093/dote/doy021.

    PMID: 29982386
  24. 24

    Can definitive chemoradiotherapy be an alternative to surgery for early-stage oesophageal cancer?

    Deng HY, Li G, Luo J, Alai G

    Interactive cardiovascular and thoracic surgery 2019; (28(1)):37-40 doi:10.1093/icvts/ivy220.

    PMID: 30007292
  25. 25

    Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3.

    Sun Y, Wang J, Li Y, et al.

    Future oncology (London, England) 2019; (15(2)):121-132 doi:10.2217/fon-2018-0493.

    PMID: 30232909
  26. 26

    Obesity and increased risk of esophageal adenocarcinoma.

    Elliott JA, Donohoe CL, Reynolds JV

    Expert review of endocrinology & metabolism 2015; (10(5)):511-523 doi:10.1586/17446651.2015.1077696.

    PMID: 30298765
  27. 27

    A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy.

    Faiz Z, Dijksterhuis WPM, Burgerhof JGM, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2019; (45(6)):931-940 doi:10.1016/j.ejso.2018.11.002.

    PMID: 30447937
  28. 28

    The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas.

    Ardito F, Panettieri E, Vellone M, et al.

    Surgery 2019; (165(4)):712-720 doi:10.1016/j.surg.2018.09.005.

    PMID: 30482518
  29. 29

    Incidence and risk factors for esophageal cancer following achalasia treatment: national population-based case-control study.

    Markar SR, Wiggins T, MacKenzie H, et al.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 2019; (32(5)) doi:10.1093/dote/doy106.

    PMID: 30809653
  30. 30

    A survival guide to HER2 testing in gastric/gastroesophageal junction carcinoma.

    Subasinghe D, Acott N, Kumarasinghe MP

    Gastrointestinal endoscopy 2019; (90(1)):44-54 doi:10.1016/j.gie.2019.03.022.

    PMID: 30928424
  31. 31

    Optimal management of gastroesophageal junction cancer.

    Greally M, Agarwal R, Ilson DH

    Cancer 2019; (125(12)):1990-2001 doi:10.1002/cncr.32066.

    PMID: 30973648
  32. 32

    Predicting the Risk of Weight Loss After Esophageal Cancer Surgery.

    Schandl A, Kauppila JH, Anandavadivelan P, et al.

    Annals of surgical oncology 2019; (26(8)):2385-2391 doi:10.1245/s10434-019-07352-5.

    PMID: 31004297
  33. 33

    The optimal neoadjuvant treatment of locally advanced esophageal cancer.

    van der Wilk BJ, Eyck BM, Lagarde SM, et al.

    Journal of thoracic disease 2019; (11(Suppl 5)):S621-S631 doi:10.21037/jtd.2018.11.143.

    PMID: 31080638
  34. 34

    Pathogenesis and Cells of Origin of Barrett's Esophagus.

    Que J, Garman KS, Souza RF, Spechler SJ

    Gastroenterology 2019; (157(2)):349-364.e1 doi:10.1053/j.gastro.2019.03.072.

    PMID: 31082367
  35. 35

    From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

    Caspa Gokulan R, Garcia-Buitrago MT, Zaika AI

    Biochimica et biophysica acta. Reviews on cancer 2019; (1872(1)):37-48 doi:10.1016/j.bbcan.2019.05.003.

    PMID: 31152823
  36. 36

    Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

    Ajani JA, D'Amico TA, Bentrem DJ, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2019; (17(7)):855-883.

    PMID: 31319389
  37. 37

    Safety, feasibility, and effect of an enhanced nutritional support pathway including extended preoperative and home enteral nutrition in patients undergoing enhanced recovery after esophagectomy: a pilot randomized clinical trial.

    Liu K, Ji S, Xu Y, et al.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 2020; (33(2)) doi:10.1093/dote/doz030.

    PMID: 31329828
  38. 38

    A Prospective Randomized Trial Comparing Jejunostomy and Nasogastric Feeding in Minimally Invasive McKeown Esophagectomy.

    Tao Z, Zhang Y, Zhu S, et al.

    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2020; (24(10)):2187-2196 doi:10.1007/s11605-019-04390-y.

    PMID: 31512101
  39. 39

    Surgical and Surgeon-Related Factors Related to Long-Term Survival in Esophageal Cancer: A Review.

    Markar SR, Lagergren J

    Annals of surgical oncology 2020; (27(3)):718-723 doi:10.1245/s10434-019-07966-9.

    PMID: 31691111
  40. 40

    Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers.

    Hölscher AH, Law S

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2020; (23(1)):3-9 doi:10.1007/s10120-019-01022-x.

    PMID: 31691875
  41. 41

    Relationship between psychological distress and health-related quality of life at each point of the treatment of esophageal cancer.

    Ohkura Y, Ichikura K, Shindoh J, et al.

    Esophagus : official journal of the Japan Esophageal Society 2020; (17(3)):312-322 doi:10.1007/s10388-019-00710-y.

    PMID: 31897762
  42. 42

    Hospital Surgical Volume and 3-Year Mortality in Severe Prognosis Cancers: A Population-Based Study Using Cancer Registry Data.

    Taniyama Y, Tabuchi T, Ohno Y, et al.

    Journal of epidemiology 2021; (31(1)):52-58 doi:10.2188/jea.JE20190242.

    PMID: 31932528
  43. 43

    Preoperative weight loss is associated with poorer prognosis in operable esophageal cancer patients: A single-center retrospective analysis of a large cohort of Chinese patients.

    Zhang S, Tan Y, Cai X, et al.

    Journal of Cancer 2020; (11(7)):1994-1999 doi:10.7150/jca.40344.

    PMID: 32194811
  44. 44

    The relationship between metabolic syndrome and increased risk of Barrett's esophagus: an updated systematic review and meta-analysis.

    Karimian M, Salamati M, Azami M

    BMC gastroenterology 2020; (20(1)):138 doi:10.1186/s12876-020-01267-2.

    PMID: 32375671
  45. 45

    Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies.

    Moentenich V, Gebauer F, Comut E, et al.

    Oncology letters 2020; (19(6)):3665-3670 doi:10.3892/ol.2020.11520.

    PMID: 32391091
  46. 46

    International consensus on the diagnosis and management of dumping syndrome.

    Scarpellini E, Arts J, Karamanolis G, et al.

    Nature reviews. Endocrinology 2020; (16(8)):448-466 doi:10.1038/s41574-020-0357-5.

    PMID: 32457534
  47. 47

    Persistent cough: An unexpected diagnosis.

    Panda SK, Satyanarayan B, Prasad SK, Koshy B

    Journal of family medicine and primary care 2020; (9(5)):2548-2551 doi:10.4103/jfmpc.jfmpc_41_20.

    PMID: 32754543
  48. 48

    Totally Mechanical Collard Technique for Cervical Esophagogastric Anastomosis Reduces Stricture Formation Compared with Circular Stapled Anastomosis.

    Hirano Y, Fujita T, Sato K, et al.

    World journal of surgery 2020; (44(12)):4175-4183 doi:10.1007/s00268-020-05729-2.

    PMID: 32783124
  49. 49

    Nutritional assessment and risk factors associated to malnutrition in patients with esophageal cancer.

    Cao J, Xu H, Li W, et al.

    Current problems in cancer 2021; (45(1)):100638 doi:10.1016/j.currproblcancer.2020.100638.

    PMID: 32829957
  50. 50

    Microscopic resection margins adversely influence survival rates after surgery for colorectal liver metastases: An open ambidirectional Cohort Study.

    Lee KS, Suchett-Kaye I, Abbadi R, et al.

    International journal of surgery (London, England) 2020; (83()):8-14 doi:10.1016/j.ijsu.2020.09.007.

    PMID: 32927149
  51. 51

    [Surgical treatment strategies for Siewert type II adenocarcinoma of the esophagogastric junction].

    Yan Q, Lyu ZJ, Zheng JB, Li Y

    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2020; (23(10)):1008-1012 doi:10.3760/cma.j.cn.441530-20191031-00467.

    PMID: 33054000
  52. 52

    Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?

    Khalafi S, Lockhart AC, Livingstone AS, El-Rifai W

    Cancers 2020; (12(11)) doi:10.3390/cancers12113077.

    PMID: 33105560
  53. 53

    Role of precision imaging in esophageal cancer.

    Elsherif SB, Andreou S, Virarkar M, et al.

    Journal of thoracic disease 2020; (12(9)):5159-5176 doi:10.21037/jtd.2019.08.15.

    PMID: 33145093
  54. 54

    Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance.

    Cook MB, Thrift AP

    Gastrointestinal endoscopy clinics of North America 2021; (31(1)):1-26 doi:10.1016/j.giec.2020.08.001.

    PMID: 33213789
  55. 55

    Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences.

    Shashi KK, Madan R, Hammer MM, et al.

    European journal of radiology open 2020; (7()):100291 doi:10.1016/j.ejro.2020.100291.

    PMID: 33304940
  56. 56

    Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries.

    Huang J, Koulaouzidis A, Marlicz W, et al.

    Cancers 2021; (13(1)) doi:10.3390/cancers13010141.

    PMID: 33466239
  57. 57

    Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.

    de Vos-Geelen J, Geurts SME, Nieuwenhuijzen GAP, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2021; (47(8)):2016-2022 doi:10.1016/j.ejso.2021.02.001.

    PMID: 33583629
  58. 58

    Nivolumab for the treatment of esophageal cancer.

    Mikuni H, Yamamoto S, Kato K

    Expert opinion on biological therapy 2021; (21(6)):697-703 doi:10.1080/14712598.2021.1904887.

    PMID: 33736560
  59. 59

    Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.

    Kelly RJ, Ajani JA, Kuzdzal J, et al.

    The New England journal of medicine 2021; (384(13)):1191-1203 doi:10.1056/NEJMoa2032125.

    PMID: 33789008
  60. 60

    A Meta-analysis of Jejunostomy Versus Nasoenteral Tube for Enteral Nutrition Following Esophagectomy.

    Li HN, Chen Y, Dai L, et al.

    The Journal of surgical research 2021; (264()):553-561 doi:10.1016/j.jss.2021.02.027.

    PMID: 33864963
  61. 61

    Endoscopic Ultrasound Stagingof Esophageal Cancer.

    Thakkar S, Kaul V

    Gastroenterology & hepatology 2020; (16(1)):14-20.

    PMID: 33867884
  62. 62

    Epidemiology of Barrett's Esophagus and Esophageal Carcinoma.

    Fabian T, Leung A

    The Surgical clinics of North America 2021; (101(3)):381-389 doi:10.1016/j.suc.2021.03.001.

    PMID: 34048759
  63. 63

    Surgical Management of Early Esophageal Cancer.

    Iriarte F, Su S, Petrov RV, et al.

    The Surgical clinics of North America 2021; (101(3)):427-441 doi:10.1016/j.suc.2021.03.005.

    PMID: 34048763
  64. 64

    A Canadian single institution real-world experience using the CROSS trial regimen in the treatment of oesophageal and gastroesophageal junction carcinoma.

    Khalid S, Hopman WM, Virik K

    Internal medicine journal 2022; (52(9)):1587-1595 doi:10.1111/imj.15427.

    PMID: 34139041
  65. 65

    Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial.

    Yang H, Liu H, Chen Y, et al.

    JAMA surgery 2021; (156(8)):721-729 doi:10.1001/jamasurg.2021.2373.

    PMID: 34160577
  66. 66

    The Optimal Definition of Sarcopenia for Predicting Postoperative Pneumonia after Esophagectomy in Patients with Esophageal Cancer.

    Nambara M, Miki Y, Tamura T, et al.

    World journal of surgery 2021; (45(10)):3108-3118 doi:10.1007/s00268-021-06223-z.

    PMID: 34189621
  67. 67

    The patient characteristics of esophageal carcinoma following laparoscopic myotomy for esophageal achalasia.

    Tsuboi K, Omura N, Yano F, et al.

    Langenbeck's archives of surgery 2021; (406(8)):2679-2686 doi:10.1007/s00423-021-02270-1.

    PMID: 34283301
  68. 68

    microRNA-196b promotes esophageal squamous cell carcinogenesis and chemoradioresistance by inhibiting EPHA7, thereby restoring EPHA2 activity.

    Tan X, Ren S, Fu MZ, et al.

    American journal of cancer research 2021; (11(7)):3594-3610.

    PMID: 34354862
  69. 69

    The association between hospital case-volume and postoperative outcomes after esophageal cancer surgery: A population-based retrospective cohort study.

    Kim BR, Jang EJ, Jo J, et al.

    Thoracic cancer 2021; (12(18)):2487-2493 doi:10.1111/1759-7714.14096.

    PMID: 34355527
  70. 70

    Molecular phenotyping reveals the identity of Barrett's esophagus and its malignant transition.

    Nowicki-Osuch K, Zhuang L, Jammula S, et al.

    Science (New York, N.Y.) 2021; (373(6556)):760-767 doi:10.1126/science.abd1449.

    PMID: 34385390
  71. 71

    Treatment Patterns and Outcomes in Patients with Esophageal Cancer: An Analysis of a Multidisciplinary Tumor Board Database.

    Hsu PK, Chien LI, Huang CS, et al.

    Annals of surgical oncology 2022; (29(1)):572-585 doi:10.1245/s10434-021-10568-z.

    PMID: 34387767
  72. 72

    An updated review of the TNM classification system for cancer of the oesophagus and its complications.

    López Sala P, Alberdi Aldasoro N, Fuertes Fernández I, Sáenz Bañuelos J

    Radiologia 2021; (63(5)):445-455 doi:10.1016/j.rxeng.2020.09.004.

    PMID: 34625200
  73. 73

    Racial Disparities in Esophageal Cancer.

    Pickens A

    Thoracic surgery clinics 2022; (32(1)):57-65 doi:10.1016/j.thorsurg.2021.09.004.

    PMID: 34801196
  74. 74

    Esophageal cancer: emerging therapeutics.

    Rogers JE, Sewastjanow-Silva M, Waters RE, Ajani JA

    Expert opinion on therapeutic targets 2022; (26(2)):107-117 doi:10.1080/14728222.2022.2036718.

    PMID: 35119973
  75. 75

    Impact of endoscopic ultrasonography on the accuracy of T staging in esophageal cancer and factors associated with its accuracy: A retrospective study.

    Wang M, Zhu Y, Li Z, et al.

    Medicine 2022; (101(8)):e28603 doi:10.1097/MD.0000000000028603.

    PMID: 35212271
  76. 76

    The Influence of Socioeconomic Status on Esophageal Cancer in Taiwan: A Population-Based Study.

    Chen HY, Chen IC, Chen YH, et al.

    Journal of personalized medicine 2022; (12(4)) doi:10.3390/jpm12040595.

    PMID: 35455711
  77. 77

    Hot Tea Consumption and Esophageal Cancer Risk: A Meta-Analysis of Observational Studies.

    Luo H, Ge H

    Frontiers in nutrition 2022; (9()):831567 doi:10.3389/fnut.2022.831567.

    PMID: 35479756
  78. 78

    Thoracolaparoscopic esophagectomy for esophageal cancer with a cervical incision to extract specimen.

    Hu ZH, Li RX, Wang JT, et al.

    Asian journal of surgery 2023; (46(1)):348-353 doi:10.1016/j.asjsur.2022.04.073.

    PMID: 35525693
  79. 79

    Endoscopic Management of Esophageal Cancer.

    Paiji C, Sedarat A

    Cancers 2022; (14(15)) doi:10.3390/cancers14153583.

    PMID: 35892840
  80. 80

    Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.

    Hölscher AH, Bollschweiler E, Fetzner UK, Babic B

    Updates in surgery 2023; (75(2)):329-333 doi:10.1007/s13304-022-01363-w.

    PMID: 36001282
  81. 81

    The role of dietary carotenoids in preventing the development of esophageal squamous cell carcinoma.

    Lu Y, Zhao W, Xie P, et al.

    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024; (94(1)):10-18 doi:10.1024/0300-9831/a000770.

    PMID: 36200170
  82. 82

    Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time.

    Li M, Park JY, Sheikh M, et al.

    Gut 2023; (72(5)):846-854 doi:10.1136/gutjnl-2022-328233.

    PMID: 36241389
  83. 83

    Immunotherapy in the Management of Esophagogastric Cancer: A Practical Review.

    Patruni S, Fayyaz F, Bien J, et al.

    JCO oncology practice 2023; (19(3)):107-115 doi:10.1200/OP.22.00226.

    PMID: 36409967
  84. 84

    Secular Trends in Incidence of Esophageal Cancer in Taiwan from 1985 to 2019: An Age-Period-Cohort Analysis.

    Tsai MC, Chou YC, Lee YK, et al.

    Cancers 2022; (14(23)) doi:10.3390/cancers14235844.

    PMID: 36497327
  85. 85

    Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers.

    Rai V, Abdo J, Agrawal DK

    International journal of molecular sciences 2023; (24(4)) doi:10.3390/ijms24043316.

    PMID: 36834728
  86. 86

    Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and Interventions.

    Derry-Vick HM, Heathcote LC, Glesby N, et al.

    Cancers 2023; (15(5)) doi:10.3390/cancers15051381.

    PMID: 36900174
  87. 87

    Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing.

    Lavacchi D, Fancelli S, Buttitta E, et al.

    International journal of molecular sciences 2023; (24(5)) doi:10.3390/ijms24054877.

    PMID: 36902306
  88. 88

    Weight loss during neoadjuvant therapy and short-term outcomes after esophagectomy: a retrospective cohort study.

    Hirano Y, Konishi T, Kaneko H, et al.

    International journal of surgery (London, England) 2023; (109(4)):805-812 doi:10.1097/JS9.0000000000000311.

    PMID: 37010417
  89. 89

    Volume outcome relationship in postesophagectomy leak: a systematic review and meta-analysis.

    Rahouma M, Baudo M, Mynard N, et al.

    International journal of surgery (London, England) 2024; (110(4)):2349-2354 doi:10.1097/JS9.0000000000000420.

    PMID: 37052430
  90. 90

    Nutrition management by a multidisciplinary team for prevention of nutritional deficits and morbidity following esophagectomy.

    Chen J, Luo AL, Yang L, et al.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica 2023; (56()):e12421 doi:10.1590/1414-431X2023e12421.

    PMID: 37075345
  91. 91

    The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancer.

    Wong LY, Liou DZ, Backhus LM, et al.

    JTCVS open 2023; (14()):547-560 doi:10.1016/j.xjon.2023.03.015.

    PMID: 37425457
  92. 92

    Gastro-Intestinal Disorders and Micronutrient Deficiencies following Oncologic Esophagectomy and Gastrectomy.

    Teixeira Farinha H, Bouriez D, Grimaud T, et al.

    Cancers 2023; (15(14)) doi:10.3390/cancers15143554.

    PMID: 37509216
  93. 93

    Comparison of central venous catheter thoracic drainage and traditional closed thoracic drainage following minimally invasive surgery for esophageal carcinoma: a retrospective analysis.

    Zhao Y, Ma Y, Bai Z, et al.

    Journal of cardiothoracic surgery 2023; (18(1)):267 doi:10.1186/s13019-023-02373-4.

    PMID: 37794478
  94. 94

    Comparison of the subtotal and narrow gastric conduit for cervical esophagogastrostomy after esophagectomy in esophageal cancer patients: a propensity score-matched analysis.

    Sasaki K, Tsuruda Y, Shimonosono M, et al.

    Esophagus : official journal of the Japan Esophageal Society 2024; (21(1)):41-50 doi:10.1007/s10388-023-01027-7.

    PMID: 37828145
  95. 95

    Endoscopic ultrasound for structured surveillance after curative treatment of esophageal cancer.

    Bohle W, Nowack L, Schaudt A, et al.

    Zeitschrift fur Gastroenterologie 2024; (62(5)):737-746 doi:10.1055/a-2125-6923.

    PMID: 38198802
  96. 96

    Promises and Limitations of Current Models for Understanding Barrett's Esophagus and Esophageal Adenocarcinoma.

    Martinez-Uribe O, Becker TC, Garman KS

    Cellular and molecular gastroenterology and hepatology 2024; (17(6)):1025-1038 doi:10.1016/j.jcmgh.2024.01.017.

    PMID: 38325549
  97. 97

    Immunotherapy for Resectable Locally Advanced Esophageal Carcinoma.

    Fick CN, Dunne EG, Sihag S, et al.

    The Annals of thoracic surgery 2024; (118(1)):130-140 doi:10.1016/j.athoracsur.2024.02.021.

    PMID: 38408631
  98. 98

    Comparison of esophageal cancer survival after neoadjuvant chemoradiotherapy plus surgery versus definitive chemoradiotherapy: A systematic review and meta-analysis.

    Ke J, Xie Y, Huang S, et al.

    Asian journal of surgery 2024; (47(9)):3827-3840 doi:10.1016/j.asjsur.2024.02.099.

    PMID: 38448293
  99. 99

    Malnutrition and vitamin deficiencies after surgery for esophageal and gastric cancer: A metanalysis.

    Finze A, Vijgen GH, Betzler J, et al.

    Clinical nutrition ESPEN 2024; (60()):348-355 doi:10.1016/j.clnesp.2024.02.021.

    PMID: 38479934
  100. 100

    Esophageal cancer: Treatment advances and need for screening.

    Eisner DC

    JAAPA : official journal of the American Academy of Physician Assistants 2024; (37(4)):19-24 doi:10.1097/01.JAA.0001007328.84376.da.

    PMID: 38484297
  101. 101

    Preoperative ultrasound-guided dual localization with titanium clips and carbon nanoparticles for predicting the surgical approach and guiding the resection of Siewert type II esophagogastric junction adenocarcinoma.

    Wu W, Luo Z, Fang Y, et al.

    Journal of cancer research and clinical oncology 2024; (150(3)):145 doi:10.1007/s00432-024-05689-3.

    PMID: 38507110
  102. 102

    Thoracoscopic salvage esophagectomy with prophylactic mediastinal lymph node dissection after definitive chemoradiotherapy for patients with esophageal cancer.

    Abe T, Fujieda H, Higaki E, et al.

    Surgical endoscopy 2024; (38(8)):4695-4703 doi:10.1007/s00464-024-10986-6.

    PMID: 38886226
  103. 103

    Advances in the treatment of human epidermal growth factor receptor 2-positive gastric cancer.

    Kudo T

    International journal of clinical oncology 2024; (29(9)):1220-1227 doi:10.1007/s10147-024-02587-z.

    PMID: 39083154
  104. 104

    Surveillance-Associated Anxiety After Curative-Intent Cancer Surgery: A Systematic Review.

    Khatri R, Quinn PL, Wells-Di Gregorio S, et al.

    Annals of surgical oncology 2025; (32(1)):47-62 doi:10.1245/s10434-024-16287-5.

    PMID: 39343818
  105. 105

    Resectability and survival outcome in real world practice of 720 cholangiocarcinoma patients: intrahepatic, perihilar and distal cholangiocarcinoma.

    Sarkhampee P, Ouransatien W, Lertsawatvicha N, et al.

    World journal of surgical oncology 2024; (22(1)):314 doi:10.1186/s12957-024-03596-y.

    PMID: 39605039
  106. 106

    Comparison of proximal gastrectomy with tubular esophagogastric anastomosis and total gastrectomy with Roux-en-Y reconstruction in the treatment of adenocarcinoma of the esophagogastric junction of Siewert type II/III at stage II.

    Zhang Z, Zhao T, Wang Y, et al.

    BMC surgery 2024; (24(1)):382 doi:10.1186/s12893-024-02685-9.

    PMID: 39614266
  107. 107

    Outcomes of Salvage Surgery for Esophageal Carcinoma: A Nationwide Cohort Study from the Dutch Upper GI Cancer Audit.

    Visser MR, Voeten DM, Gisbertz SS, et al.

    Annals of surgical oncology 2025; (32(4)):2687-2697 doi:10.1245/s10434-024-16490-4.

    PMID: 39627639
  108. 108

    Scanxiety and Fear of Recurrence in Young Adult Female Breast and Gynaecological Cancer Survivors: Investigating Shared Mechanisms.

    Patel DS, Webster SN, Dowling EJ, et al.

    Psycho-oncology 2024; (33(12)):e70050 doi:10.1002/pon.70050.

    PMID: 39694862
  109. 109

    Lived experiences of dysphagia-related quality of life among esophageal cancer patients: a qualitative study.

    Asefa T, Tesfaye W, Bitew G, Tezera H

    Health and quality of life outcomes 2025; (23(1)):2 doi:10.1186/s12955-024-02319-x.

    PMID: 39757188
  110. 110

    HER2 Status in Gastric and Gastroesophageal Carcinomas: Evaluation of Histopathological Fingings, Paired ResectionBiopsy Specimens, and the Effect of Neoadjuvant Therapy: A Single Center Study.

    Yuzuguldu RI, Sagol O, Unlu M, et al.

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2025; (36(6)):357-370 doi:10.5152/tjg.2025.24488.

    PMID: 39840863
  111. 111

    Contemporary management of advanced gastric and gastroesophageal adenocarcinomas.

    Rogers JE, Ajani JA

    Expert review of anticancer therapy 2025; 1-7 doi:10.1080/14737140.2025.2463493.

    PMID: 39918299
  112. 112

    [Comparative study with propensity score matching of gastrectomy versus total gastrectomy for the safety and prognosis of Siewert types Ⅱ and Ⅲ adenocarcinoma of the esophagogastric junction].

    Wang B, Yang R, Qiao Y, et al.

    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2025; (28(2)):169-177 doi:10.3760/cma.j.cn441530-20240228-00077.

    PMID: 39971568
  113. 113

    FAPI-PET/CT guided radiotherapy for patients with esophageal cancer.

    Kröger K, Pepper NB, Ventura D, et al.

    Radiation oncology (London, England) 2025; (20(1)):29 doi:10.1186/s13014-025-02606-x.

    PMID: 40022163
  114. 114

    Post-Esophagectomy Dumping Syndrome: Assessing Quality of Life of Long-Term Survivors.

    Dellaportas D, Margaris I, Tsalavoutas E, et al.

    Journal of clinical medicine 2025; (14(10)) doi:10.3390/jcm14103587.

    PMID: 40429582
  115. 115

    Four-step formula for the Siewert classification of adenocarcinomas of the esophagogastric junction: a computed tomography-based quantitative model.

    Liu YT, Li YA, Li JZ, et al.

    Expert review of medical devices 2025; (22(7)):747-755 doi:10.1080/17434440.2025.2510534.

    PMID: 40439686
  116. 116

    Enhancing survival in locally advanced esophageal cancer: a comparative analysis of neoadjuvant immunotherapy versus conventional neoadjuvant therapies using the SEER database.

    Tian Q, Lin J, Hu L, et al.

    Journal of thoracic disease 2025; (17(5)):2778-2801 doi:10.21037/jtd-24-1905.

    PMID: 40529733
  117. 117

    Excellent patient-reported long-term quality of life after an Ivor Lewis esophagectomy for cancer.

    Blumenthaler AN, Feizpour CA, Jalal SI, et al.

    Frontiers in surgery 2025; (12()):1491498 doi:10.3389/fsurg.2025.1491498.

    PMID: 40672440
  118. 118

    Preliminary Development of a Health Education Program to Improve Psychological Distress Among Patients with Esophageal Cancer and Their Partners: A Narrative Review.

    Wei M, Chan CMH, Yusuf A, Marzuki MA

    Healthcare (Basel, Switzerland) 2025; (13(17)) doi:10.3390/healthcare13172210.

    PMID: 40941562
  119. 119

    Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: a prospective longitudinal study.

    Shah MS, Memon JA, Malik U, et al.

    Clinical imaging 2025; (128()):110634 doi:10.1016/j.clinimag.2025.110634.

    PMID: 41077027
  120. 120

    Exploring the factors influencing anticipatory grief in esophageal cancer patients: A cross-sectional study.

    Hu X, Guzhanuer T, Ding C, Liu X

    European journal of oncology nursing : the official journal of European Oncology Nursing Society 2025; (79()):103015 doi:10.1016/j.ejon.2025.103015.

    PMID: 41161137
  121. 121

    Integrated bioinformatics analysis of differences between EAC and ESCC.

    Lyu Q, Chai Y, Chen W, et al.

    BMC cancer 2025; (25(1)):1668 doi:10.1186/s12885-025-15090-z.

    PMID: 41162922
  122. 122

    Psychological distress and its influencing factors in esophageal cancer patients undergoing radiotherapy: a longitudinal study.

    Li J, Li X, Chen J, et al.

    Frontiers in oncology 2025; (15()):1582870 doi:10.3389/fonc.2025.1582870.

    PMID: 41278267
  123. 123

    "You Always Worry": Scan-Related Anxiety Among Patients With Metastatic Lung Cancer.

    Derry-Vick H, Prigerson HG, Hahne J, et al.

    Journal of the American College of Radiology : JACR 2025; (22(12)):1572-1577 doi:10.1016/j.jacr.2025.08.021.

    PMID: 41338711
  124. 124

    Nutritional approach to dumping syndrome.

    Scarpellini E, Siquini W

    Best practice & research. Clinical gastroenterology 2025; (79()):102075 doi:10.1016/j.bpg.2025.102075.

    PMID: 41423304
  125. 125

    Impact of hospital volume on outcomes of esophagectomy for esophageal cancer: analysis of a prospective multicenter database.

    Mao YS, Gao SG, Guan FS, et al.

    Surgical endoscopy 2026; (40(3)):2279-2288 doi:10.1007/s00464-025-12474-x.

    PMID: 41436612
  126. 126

    Dose dependent nanoparticle albumin bound paclitaxel + pembrolizumab alters the immune micro environment in a esophageal homograft mouse model.

    Liang G, Yu H, Wu S, et al.

    Journal of chemotherapy (Florence, Italy) 2025; 1-16 doi:10.1080/1120009X.2025.2607798.

    PMID: 41454603
  127. 127

    Targeting Esophageal Cancer: Promising Drugs for the Clinical Landscape and Key Knowledge Gaps.

    Akumaga T, Park H, Lockhart AC, Jin RU

    Drug design, development and therapy 2025; (19()):12049-12076 doi:10.2147/DDDT.S543686.

    PMID: 41502549
  128. 128

    Updated evidence on the accuracy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in esophageal cancer staging: a systematic review of studies published between 2017 and 2024.

    Alharthi OA, Esailan MM, Sameer Tammar R, et al.

    Quantitative imaging in medicine and surgery 2026; (16(2)):181 doi:10.21037/qims-2025-1486.

    PMID: 41669404
  129. 129

    Glucocorticoid Therapy and Miglitol Ameliorate Reactive Hypoglycemia Secondary to Late Dumping Syndrome: A Case Report.

    Saito M, Uchino H, Yoshida A, et al.

    Internal medicine (Tokyo, Japan) 2026; doi:10.2169/internalmedicine.6534-25.

    PMID: 41730617